NanoMab’s Voting Power in Radiopharm Diluted

Radiopharm Theranostics Limited (AU:RAD) has released an update.

NanoMab Technology Limited has reported a change in its substantial holding in Radiopharm Theranostics Limited, with its voting power decreasing from 8.6% to 6.1% due to dilution from various share issues. No new associates have been reported and there have been no changes in the nature of associations with the substantial holder. The change in interest was recorded on May 5, 2024, and the notice was signed by NanoMab’s Director, Ho, Hin Hung Henry, on May 21, 2024.

For further insights into AU:RAD stock, check out TipRanks’ Stock Analysis page.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


More Related Articles

Info icon

This data feed is not available at this time.

Sign up for the TradeTalks newsletter to receive your weekly dose of trading news, trends and education. Delivered Wednesdays.